Publication:
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria

Simple item page
dc.contributor.authorSteffen Borrmannen_US
dc.contributor.authorTim Petoen_US
dc.contributor.authorRobert W. Snowen_US
dc.contributor.authorWin Gutteridgeen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.otherKenya Medical Research Instituteen_US
dc.contributor.otherUniversitat Heidelbergen_US
dc.contributor.otherJohn Radcliffe Hospitalen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMedicines for Malaria Ventureen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-12T02:37:28Z
dc.date.available2018-07-12T02:37:28Z
dc.date.issued2008-11-01en_US
dc.identifier.citationPLoS Medicine. Vol.5, No.11 (2008), 1546-1552en_US
dc.identifier.doi10.1371/journal.pmed.0050227en_US
dc.identifier.issn15491676en_US
dc.identifier.issn15491277en_US
dc.identifier.other2-s2.0-56749176780en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/19498
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=56749176780&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleRevisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malariaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=56749176780&origin=inwarden_US

Files

Collections

Scopus 2006-2010

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.